Founding father recognised for outstanding cancer care
15 November 2017
A founding father of Melanoma Institute Australia, Professor William McCarthy AM, has been recognised for his contributions to cancer care by being awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care at the Clinical Oncology Society of Australia dinner last night.
The award is given annually to a national leader who has made a significant contribution over a long period of time to cancer care through research, clinical leadership and community service.
One nominee wrote: “There is no questioning Professor McCarthy’s contribution to the improvement of the care of patients with cancer and in particular patients with melanoma in his home state of New South Wales, in Australia and internationally…. in the roles of clinician, researcher, teacher and contributor to national forums related to the disease.”
The former Executive Director of the Sydney Melanoma Unit (now known as Melanoma Institute Australia) has led the world in melanoma education, general medical education and melanoma surgery.
Professor McCarthy graduated from The University of Sydney’s Faculty of Medicine in 1958 and trained in surgery at St Vincent’s Hospital Sydney. He then obtained a Master’s Degree in Medical Education at the University of Illinois, Chicago, and worked in various surgical registrar postings in the United Kingdom.
Returning to Sydney in 1968, Professor McCarthy was appointed a Lecturer in Surgery at The University of Sydney and a Visiting Medical Officer at Sydney Hospital where he worked with Professor Gerry Milton in the Sydney Melanoma Unit.
His academic achievements include some 180 peer‐reviewed publications over a span of 50 years. He was promoted steadily in the University, becoming Professor of Surgery (Melanoma and Skin Oncology) in 1990; a post he held until his retirement in 2005 when he was appointed Professor Emeritus.
His contributions were recognised by appointment as a Member (AM) of the Order of Australia in 1993 and receipt of the World Health Organisation Melanoma Award in 2001. He served on the Clinical Oncology Society of Australia Council and was President in 1992 and 1993.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.